Anti-TNF treatments in rheumatoid arthritis: economic impact of dosage modification.
de la Torre I, Valor L, Nieto JC, Hernández-Flórez D, Martinez L, Gonzalez CM, Monteagudo I, Longo JL, Montoro M, Carreño L.
de la Torre I, et al.
Expert Rev Pharmacoecon Outcomes Res. 2013 Jun;13(3):407-14. doi: 10.1586/erp.13.24.
Expert Rev Pharmacoecon Outcomes Res. 2013.
PMID: 23763534